Preclinical and Clinical Application of Extracorporeal Shockwave for Ischemic Cardiovascular Disease

Author(s):  
Hon-Kan Yip ◽  
Fan-Yen Lee ◽  
Kuan-Hung Chen ◽  
Pei-Hsun Sung ◽  
Cheuk-Kwan Sun
2011 ◽  
pp. 5-12
Author(s):  
Anh Tien Hoang ◽  
Van Minh Huynh ◽  
Khanh Hoang ◽  
Huu Dang Tran ◽  
Viet An Tran

NT-ProBNP is a high value cardiac biomarker and widely applies in many cardiovascular diseases. The evaluation of concentration of NT-ProBNP needs the concern about age, gender, obesity and especially we need each cut-off point for each cause of cardiovascular disease in evaluation and clinical application. Because NT-ProBNP is a new cardiac marker and has been researched in 5 recent years, the cut-off of NT-ProBNP is still being studied for the clinical application in cardiovascular diseases. Only the cut-off of NT-ProBNP in diagnosis heart failure was guided by European Society of Cardiology. The meaning of introduce cut-off value of value plays an role as pilot study for the other relate study and brings the NT-ProBNP closely approach to clinical application.


2006 ◽  
Vol 254 ◽  
pp. 1-3

In a nutshellVitamin D does appear to be an important factor in CVD, including hypertension, but clinical application (apart from renal hypertension) is unproven.Even so, vitamin D is so important to good health, and inadequate status so common, that clinicians should always bear it in mind, particularly in those with less sun exposure.


Author(s):  
Aseel Alfuhied ◽  
Prathap Kanagala ◽  
Gerry P. McCann ◽  
Anvesha Singh

AbstractThe left atrium (LA) plays a vital role in maintaining normal cardiac function. LA volume and function have been utilised as important imaging biomarkers, with their prognostic value demonstrated in multiple cardiac conditions. More recently, there has been a sharp increase in the number of publications utilising LA strain by echocardiography and cardiac magnetic resonance (CMR) imaging. However, little is known about its prognostic value or reproducibility as a technique. In this review, we aim to highlight the conventional and novel imaging techniques available for LA assessment, using echocardiography and CMR, their role as an imaging biomarker in cardiovascular disease, the reproducibility of the techniques and the current limitations to their clinical application. We identify a need for further standardisation of techniques, with establishment of ‘normal’ cut-offs before routine clinical application can be made.


Sign in / Sign up

Export Citation Format

Share Document